EULAC PerMed
Widening EU-LAC policy and research cooperation in Personalised MedicineFunding programme: Horizon 2020 (N 825173)
Budget: €2M
Coordinator: INSTITUTO DE SALUD CARLOS III (ISCIII)
Duration: 3 years (Jan 2019 - Dec 2021) - extended until Dec 2022
This project aim to: Map existing programmes, capacities and expertise and gaps in LAC countries; Facilitate the incorporation of CELAC countries in the International Consortium on Personalized Medicine (ICPerMed) and in the ERA-Net ERAPerMed; Foster the participation of LAC countries in research mobility and transnational projects on PerMed, and create a platform for EU‐LAC collaboration on PerMed-focused clinical trials; and Promote cross-border learning from Research & Innovation (R&I) and ELSA for implementing innovations between research capacities based in the EU and LAC countries.
ECRIN's role in EULAC Permed : ECRIN participates in the WP dedicated to capacity building and training, helping to identify training needs in the Latin American and Caribbean (LAC) setting and to link with existing training initiatives for personalised medicine (PM). In particular, ECRIN organizes two “Technical Workshops” that bring together experts from Europe and LAC to exchange on research methodologies for PM. ECRIN also develops the Clinical Trials Helpdesk.
